Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Hepatocellular 35Carcinoma, Non-Small-Cell Lung 32Colorectal Neoplasms 19Esophageal Squamous Cell Carcinoma 18Stomach Neoplasms 17Squamous Cell Carcinoma of Head and Neck 16Rectal Neoplasms 11Cholangiocarcinoma 11Head and Neck Neoplasms 10Small Cell Lung Carcinoma 9Lung Neoplasms 9Esophageal Neoplasms 9Triple Negative Breast Neoplasms 8Uterine Cervical Neoplasms 7Nasopharyngeal Carcinoma 7Urinary Bladder Neoplasms 6Recurrence 6Pancreatic Neoplasms 6Neoplasms 6Colonic Neoplasms 6Melanoma 5Hodgkin Disease 5Biliary Tract Neoplasms 4Adenocarcinoma of Lung 4Sarcoma 3Non-Muscle Invasive Bladder Neoplasms 3Neoplasm Metastasis 3NSCLC 3Locally Advanced Rectal Cancer 3Liver Neoplasms 3

Interventions

Tomography, X-Ray Computed 3Positron Emission Tomography Computed Tomography 2Oxygen 2Laryngeal Masks 2tislelizumab 1Tomography 1Thoracoscopy 1Radiofrequency Ablation 1Positron-Emission Tomography 1Oxycodone 1Nitrous Oxide 1Neuromuscular Blockade 1Magnetic Resonance Imaging 1Limonene 1Indocyanine Green 1Fluoroscopy 1Fluorodeoxyglucose F18 1Diagnostic Imaging 1Carbon Dioxide 1Blood Specimen Collection 1Anti-Bacterial Agents 1Anterior Temporal Lobectomy 1Anesthetics, Local 1Anesthesia, General 1Anesthesia 14-(3-fluoropropyl)glutamic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Multiple Pulmonary Nodules × tislelizumab × Clear all
NCT04047186 2025-09-23

Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules

Tongji Hospital

Phase 2 Completed
12 enrolled
Thoracic

Lung Neoplasms, Multiple Pulmonary Nodules

Data powered by HemOnc (CC BY 4.0) Colophon âš¡